Vaccination

Total number of HPV vaccination encounters down during pandemic

There was an increase in human papillomavirus (HPV) vaccination per encounter for pediatric patients aged 9 to 22 years, despite a decrease in overall encounters associated with the COVID-19 pandemic, according to a research ...

Medical economics

Costs cast cloud over Nigeria's HPV vaccine plan

Nigeria's latest target for introducing a life-saving vaccine against cervical cancer has been branded unrealistic by health specialists as cost concerns have yet to be addressed, leaving thousands of Nigerian women at risk.

Oncology & Cancer

Getting ahead of head and neck cancer

Many symptoms of head and neck cancer are hard to miss—a lump in the neck, persistent hoarseness, a mouth sore that doesn't heal—which is good news for early detection as long as symptoms aren't dismissed.

Medications

New therapeutic option for head and neck carcinomas

The various manifestations of head and neck carcinomas rank sixth in frequency worldwide and are fatal for about half a million people every year. In a quarter of cases, head and neck squamous cell carcinoma (HNSCC) is caused ...

page 7 from 40